Found: 2
Select item for more details and to access through your institution.
Impact of CYP2C19 metabolizer status on esophageal mucosal inflammation, acid exposure, and motility among patients on chronic proton-pump inhibitor therapy with refractory symptoms of gastroesophageal reflux disease.
- Published in:
- Journal of the Canadian Association of Gastroenterology, 2024, v. 7, n. 3, p. 238, doi. 10.1093/jcag/gwae005
- By:
- Publication type:
- Article
Severe acute hypokalaemia associated with piperacillin/tazobactam in an HIV-infected patient under antiretroviral therapy with tenofovir alafenamide: case report and literature review.
- Published in:
- 2020
- By:
- Publication type:
- journal article